Predictions
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.05
03.02.24
03.02.24
-
03.02.25
03.02.25
1.90%
17.02.24
17.02.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€8.35
02.02.24
02.02.24
-
02.02.25
02.02.25
0.60%
03.02.24
03.02.24
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€8.37
01.02.24
01.02.24
-
01.02.25
01.02.25
0.36%
02.02.24
02.02.24
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.06
26.12.23
26.12.23
-
26.12.24
26.12.24
-8.96%
11.01.24
11.01.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€0.90
11.11.23
11.11.23
-
11.11.24
11.11.24
-
11.11.23
11.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€0.81
05.11.23
05.11.23
-
05.11.24
05.11.24
15.43%
11.11.23
11.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.01
03.09.23
03.09.23
-
03.09.24
03.09.24
-19.80%
05.11.23
05.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
ifa systems AG
Start price
Target price
Perf. (%)
€3.16
20.08.23
20.08.23
€0.000
20.08.24
20.08.24
-5.70%
03.09.23
03.09.23
Revenue decline/stagnation expected
Decining EBIT margin than peer group
EBIT decline/stagnation expected
High valuation
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.28
06.08.23
06.08.23
-
06.08.24
06.08.24
-12.50%
20.08.23
20.08.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
CytoTools AG
Start price
Target price
Perf. (%)
€1.15
28.11.22
28.11.22
-
28.11.23
28.11.23
91.30%
24.04.23
24.04.23
Probably not worthwhile Investment
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.72
07.08.22
07.08.22
-
07.08.23
07.08.23
-13.98%
26.08.22
26.08.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Nanorepro AG
Start price
Target price
Perf. (%)
€3.97
27.07.22
27.07.22
€15.00
27.08.22
27.08.22
-14.12%
28.08.22
28.08.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Very high dividend yield expected
Top 10 in its market